KALLYOPE Trademark

Trademark Overview


On Wednesday, December 26, 2018, a trademark application was filed for KALLYOPE with the United States Patent and Trademark Office. The USPTO has given the KALLYOPE trademark a serial number of 88242123. The federal status of this trademark filing is REGISTERED as of Tuesday, October 4, 2022. This trademark is owned by Kallyope, Inc.. The KALLYOPE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability ; pharmaceutical preparations and substances for treatment of diseases related to the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules

Active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability; biochemicals for in vitro and in vivo scientific or research use; ; Active chemical ingredients for scientific or research use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability

medical and scientific research in the fields of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability; scientific and medical research and development; biological research and development; bacteriological research and development; pharmaceutical scientific research and development; pharmaceutical new product research and development for others; scientific chemical, biochemical, biotechnological, biological and bacteriological research and analysis; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; medical and scientific research in the fields of diseases of the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules
kallyope

General Information


Serial Number88242123
Word MarkKALLYOPE
Filing DateWednesday, December 26, 2018
Status700 - REGISTERED
Status DateTuesday, October 4, 2022
Registration Number6866593
Registration DateTuesday, October 4, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements


Goods and Servicespharmaceutical preparations and substances for the treatment of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability ; pharmaceutical preparations and substances for treatment of diseases related to the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules
Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability; biochemicals for in vitro and in vivo scientific or research use; ; Active chemical ingredients for scientific or research use in the manufacture of pharmaceuticals for the treatment of gastrointestinal diseases, metabolic diseases, microbiome related conditions, and neurological diseases and disorders, and any disease or disorder associated with intestinal permeability
Goods and Servicesmedical and scientific research in the fields of gastrointestinal diseases, metabolic diseases, microbiome-related conditions, neurological diseases and disorders, and diseases and disorders associated with intestinal permeability; scientific and medical research and development; biological research and development; bacteriological research and development; pharmaceutical scientific research and development; pharmaceutical new product research and development for others; scientific chemical, biochemical, biotechnological, biological and bacteriological research and analysis; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; medical and scientific research in the fields of diseases of the gut-brain axis, gut-brain circuits and gut-restricted and gut-targeted molecules

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, January 17, 2019
Primary Code001
First Use Anywhere DateTuesday, June 1, 2021
First Use In Commerce DateTuesday, June 1, 2021

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 17, 2019
Primary Code005
First Use Anywhere DateTuesday, June 1, 2021
First Use In Commerce DateTuesday, June 1, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 17, 2019
Primary Code042
First Use Anywhere DateWednesday, February 7, 2018
First Use In Commerce DateWednesday, February 7, 2018

Trademark Owner History


Party NameKallyope, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Party NameKallyope, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Party NameKallyope, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Tuesday, October 4, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 4, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, August 27, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 2, 2022TEAS EXTENSION RECEIVED
Tuesday, February 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 1, 2022NON-FINAL ACTION E-MAILED
Tuesday, February 1, 2022SU - NON-FINAL ACTION - WRITTEN
Tuesday, January 4, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, December 10, 2021USE AMENDMENT FILED
Tuesday, January 4, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 10, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, December 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 2, 2021SOU EXTENSION 4 GRANTED
Thursday, December 2, 2021SOU EXTENSION 4 FILED
Thursday, December 2, 2021TEAS EXTENSION RECEIVED
Thursday, June 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 1, 2021SOU EXTENSION 3 GRANTED
Tuesday, June 1, 2021SOU EXTENSION 3 FILED
Tuesday, June 1, 2021TEAS EXTENSION RECEIVED
Wednesday, December 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 30, 2020SOU EXTENSION 2 GRANTED
Monday, November 30, 2020SOU EXTENSION 2 FILED
Monday, November 30, 2020TEAS EXTENSION RECEIVED
Saturday, May 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 21, 2020SOU EXTENSION 1 GRANTED
Thursday, May 21, 2020SOU EXTENSION 1 FILED
Thursday, May 21, 2020TEAS EXTENSION RECEIVED
Tuesday, December 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2019ASSIGNED TO LIE
Saturday, August 31, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 30, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 21, 2019NON-FINAL ACTION E-MAILED
Thursday, March 21, 2019NON-FINAL ACTION WRITTEN
Monday, March 18, 2019ASSIGNED TO EXAMINER
Thursday, January 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 29, 2018NEW APPLICATION ENTERED IN TRAM